Lynparza 150 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FZ1NX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,135
Award facts
- Contract value 100% obligated
- $21,135.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,135.20 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lynparza 150 mg tablets (120-count units). This firm fixed price, non-set-aside contract is scheduled for completion by October 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated substantial capability in fulfilling Defense Logistics Agency requirements through competitive procurement processes. The company's federal contract portfolio encompasses diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Lynparza, an oncology medication, represents a routine fulfillment under the company's established prime vendor agreement with DLA, reflecting the agency's reliance on AmerisourceBergen's distribution infrastructure for pharmaceutical support to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FZ1NX?
SPE2DB25FZ1NX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZ1NX worth?
The government has obligated $21,135 on SPE2DB25FZ1NX.
Is contract SPE2DB25FZ1NX an order under another contract?
Yes. SPE2DB25FZ1NX is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1NX competed?
The extent of competition for SPE2DB25FZ1NX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award